Article Details

Zacks Investment Research Lowers Novus Therapeutics (NVUS) to Sell

Retrieved on: 2018-11-23 21:07:30

Tags for this article:

Click the tags to see associated articles and topics

Zacks Investment Research Lowers Novus Therapeutics (NVUS) to Sell. View article details on hiswai:

Excerpt

<div>Finally, <b>Vanguard Group</b> Inc. raised its stake in shares of Novus Therapeutics by 73.5% in the third quarter. <b>Vanguard Group</b> Inc. now owns 135,599 ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up